Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Company news
>
2018
Company news, 2018
Torrey Pines Investment's i2020 Accelerator to Advance Snap Bio's Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases
SAN DIEGO, Nov.
Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry
Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry which is to be held from August 26thto 31st2018at Heinrich Heine University (Dusseldorf, Germany)...
Meet ChemDiv at EFMC-ISMC’18 International Symposium on Medicinal Chemistry
Join ChemDiv at EFMC-ISMC’18 on September 2-6, 2018 in Ljubljana, Slovenia.
ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen
SAN DIEGO, CA (January 23, 2018) –— ChemDiv, Inc.
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
Regen BioPharma, Inc.
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
SAN DIEGO and BONN, Jan.
1
